Literature DB >> 11899618

Synthesis of influenza neuraminidase inhibitors.

A F Abdel-Magid1, C A Maryanoff, S J Mehrman.   

Abstract

Influenza neuraminidase inhibitors provide a means to combat flu, a potentially very serious disease. For the first time, there is a way to treat influenza by blocking the influenza enzyme neuraminidase to stop or slow the progression of infection. The diverse structures and synthesis of several influenza neuraminidase inhibitors are discussed. Contributions from chemical process development groups are highlighted for those compounds that have reached the market, such as zanamivir and oseltamivir phosphate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11899618

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  6 in total

1.  Solid-phase chemoenzymatic synthesis of C-sialosides.

Authors:  Sultan N Baytas; Qun Wang; Nathalie A Karst; Jonathan S Dordick; Robert J Linhardt
Journal:  J Org Chem       Date:  2004-10-01       Impact factor: 4.354

2.  Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, 2000-2005.

Authors:  Patrick H Peters; Anne Moscona; Kathy L Schulman; Charles E Barr
Journal:  Medscape J Med       Date:  2008-06-04

Review 3.  Antiviral agents active against influenza A viruses.

Authors:  Erik De Clercq
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

Review 4.  Selected β2-, β3- and β2,3-Amino Acid Heterocyclic Derivatives and Their Biological Perspective.

Authors:  Urszula Bąchor; Marcin Mączyński
Journal:  Molecules       Date:  2021-01-15       Impact factor: 4.411

Review 5.  Recent progress in chemical approaches for the development of novel neuraminidase inhibitors.

Authors:  Ahmed Mahal; Meitao Duan; Dhafer S Zinad; Ranjan K Mohapatra; Ahmad J Obaidullah; Xiaoyi Wei; Manoj K Pradhan; Debadutta Das; Venkataramana Kandi; Hany S Zinad; Quanhong Zhu
Journal:  RSC Adv       Date:  2021-01-06       Impact factor: 3.361

Review 6.  Molecular strategies to inhibit the replication of RNA viruses.

Authors:  Pieter Leyssen; Erik De Clercq; Johan Neyts
Journal:  Antiviral Res       Date:  2008-02-04       Impact factor: 5.970

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.